210 related articles for article (PubMed ID: 10405888)
1. Enhanced protection against viral infection by co-administration of plasmid DNA coding for viral antigen and cytokines in mice.
Operschall E; Schuh T; Heinzerling L; Pavlovic J; Moelling K
J Clin Virol; 1999 Jun; 13(1-2):17-27. PubMed ID: 10405888
[TBL] [Abstract][Full Text] [Related]
2. Mechanism of protection against influenza A virus by DNA vaccine encoding the hemagglutinin gene.
Operschall E; Pavlovic J; Nawrath M; Mölling K
Intervirology; 2000; 43(4-6):322-30. PubMed ID: 11251388
[TBL] [Abstract][Full Text] [Related]
3. DNA-based vaccine against La Crosse virus: protective immune response mediated by neutralizing antibodies and CD4+ T cells.
Schuh T; Schultz J; Moelling K; Pavlovic J
Hum Gene Ther; 1999 Jul; 10(10):1649-58. PubMed ID: 10428210
[TBL] [Abstract][Full Text] [Related]
4. DNA vaccination against La Crosse virus.
Pavlovic J; Schultz J; Hefti HP; Schuh T; Mölling K
Intervirology; 2000; 43(4-6):312-21. PubMed ID: 11251387
[TBL] [Abstract][Full Text] [Related]
5. Protection and antibody responses in different strains of mouse immunized with plasmid DNAs encoding influenza virus haemagglutinin, neuraminidase and nucleoprotein.
Chen Z; Yoshikawa T; Kadowaki SE; Hagiwara Y; Matsuo K; Asanuma H; Aizawa C; Kurata T; Tamura SI
J Gen Virol; 1999 Oct; 80 ( Pt 10)():2559-2564. PubMed ID: 10573147
[TBL] [Abstract][Full Text] [Related]
6. Strategies for inducing protection against avian influenza A virus subtypes with DNA vaccines.
Kodihalli S; Kobasa DL; Webster RG
Vaccine; 2000 May; 18(23):2592-9. PubMed ID: 10775793
[TBL] [Abstract][Full Text] [Related]
7. Comparative analysis of antibody induction and protection against influenza virus infection by DNA immunization with HA, HAe, and HA1 in mice.
Chen J; Liu Q; Chen Q; Xiong C; Yao Y; Wang H; Wang H; Chen Z
Arch Virol; 2014 Apr; 159(4):689-700. PubMed ID: 24132721
[TBL] [Abstract][Full Text] [Related]
8. Enhanced protection against a lethal influenza virus challenge by immunization with both hemagglutinin- and neuraminidase-expressing DNAs.
Chen Z; Matsuo K; Asanuma H; Takahashi H; Iwasaki T; Suzuki Y; Aizawa C; Kurata T; Tamura S
Vaccine; 1999 Feb; 17(7-8):653-9. PubMed ID: 10067670
[TBL] [Abstract][Full Text] [Related]
9. Co-administration of certain DNA vaccine combinations expressing different H5N1 influenza virus antigens can be beneficial or detrimental to immune protection.
Patel A; Gray M; Li Y; Kobasa D; Yao X; Kobinger GP
Vaccine; 2012 Jan; 30(3):626-36. PubMed ID: 22119588
[TBL] [Abstract][Full Text] [Related]
10. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. I. Vaccine characterization and efficacy studies in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1223-38. PubMed ID: 10195636
[TBL] [Abstract][Full Text] [Related]
11. Induction of humoral and cellular immunity against influenza virus by immunization of newborn mice with a plasmid bearing a hemagglutinin gene.
Bot A; Antohi S; Bot S; Garcia-Sastre A; Bona C
Int Immunol; 1997 Nov; 9(11):1641-50. PubMed ID: 9418125
[TBL] [Abstract][Full Text] [Related]
12. Virus-like particle vaccine conferred complete protection against a lethal influenza virus challenge.
Galarza JM; Latham T; Cupo A
Viral Immunol; 2005; 18(2):365-72. PubMed ID: 16035948
[TBL] [Abstract][Full Text] [Related]
13. Cytokine GM-CSF genetic adjuvant facilitates prophylactic DNA vaccine against pseudorabies virus through enhanced immune responses.
Yoon HA; Aleyas AG; George JA; Park SO; Han YW; Lee JH; Cho JG; Eo SK
Microbiol Immunol; 2006; 50(2):83-92. PubMed ID: 16490926
[TBL] [Abstract][Full Text] [Related]
14. The genetic adjuvant IL-12 enhances the protective efficacy of a DNA vaccine for Venezuelan equine encephalitis virus delivered by intramuscular injection in mice.
Suschak JJ; Bagley K; Six C; Shoemaker CJ; Kwilas S; Spik KW; Dupuy LC; Schmaljohn CS
Antiviral Res; 2018 Nov; 159():113-121. PubMed ID: 30268913
[TBL] [Abstract][Full Text] [Related]
15. A novel influenza subunit vaccine composed of liposome-encapsulated haemagglutinin/neuraminidase and IL-2 or GM-CSF. II. Induction of TH1 and TH2 responses in mice.
Babai I; Samira S; Barenholz Y; Zakay-Rones Z; Kedar E
Vaccine; 1999 Mar; 17(9-10):1239-50. PubMed ID: 10195637
[TBL] [Abstract][Full Text] [Related]
16. Plasmid DNA encoding influenza virus haemagglutinin induces Th1 cells and protection against respiratory infection despite its limited ability to generate antibody responses.
Johnson PA; Conway MA; Daly J; Nicolson C; Robertson J; Mills KH
J Gen Virol; 2000 Jul; 81(Pt 7):1737-45. PubMed ID: 10859379
[TBL] [Abstract][Full Text] [Related]
17. Synthetic Toll-Like Receptor 4 (TLR4) and TLR7 Ligands Work Additively via MyD88 To Induce Protective Antiviral Immunity in Mice.
Goff PH; Hayashi T; He W; Yao S; Cottam HB; Tan GS; Crain B; Krammer F; Messer K; Pu M; Carson DA; Palese P; Corr M
J Virol; 2017 Oct; 91(19):. PubMed ID: 28724768
[TBL] [Abstract][Full Text] [Related]
18. Protective immunity elicited by vaccination with DNA encoding for a B cell and a T cell epitope of the A/PR/8/34 influenza virus.
Casares S; Brumeanu TD; Bot A; Bona CA
Viral Immunol; 1997; 10(3):129-36. PubMed ID: 9344335
[TBL] [Abstract][Full Text] [Related]
19. Protection against avian influenza H9N2 virus challenge by immunization with hemagglutinin- or neuraminidase-expressing DNA in BALB/c mice.
Qiu M; Fang F; Chen Y; Wang H; Chen Q; Chang H; Wang F; Wang H; Zhang R; Chen Z
Biochem Biophys Res Commun; 2006 May; 343(4):1124-31. PubMed ID: 16580631
[TBL] [Abstract][Full Text] [Related]
20. C3d enhancement of antibodies to hemagglutinin accelerates protection against influenza virus challenge.
Ross TM; Xu Y; Bright RA; Robinson HL
Nat Immunol; 2000 Aug; 1(2):127-31. PubMed ID: 11248804
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
